Trial no.:
|
PACTR202212516035370 |
Date of Approval:
|
11/12/2022 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Early outcome measurement of effectiveness of Continuous passive motion and conventional physical therapy in knee function after retrograde femoral nailing |
Official scientific title |
Comparative analysis of Continuous passive motion and conventional physical therapy in preventing knee stiffness after retrograde femoral nailing |
Brief summary describing the background
and objectives of the trial
|
Intramedullary has evolved to become the gold standard for diaphyseal femoral fractures. The antegrade been the most commonly used; retrograde femoral nailing is increasingly being used for distal femoral factures, bilateral femoral fractures, ipsilateral pelvic and hip fractures, floating knee and obesity. one of the major drawbacks of retrograde femoral nailing is violation of virgin nail with increased predisposition to knee sepsis, knee pain, and postoperative knee joint stiffness. Postoperative rehabilitation protocol that incorporates active and passive knee motion in the early is desirable to reduce the untoward complications. To achieve this aim, conventional physical therapy (CPT) are instituted early postoperative period either alone or in combination with continuous passive motion (CPM) with varying reported successes. There is no study done comparing the effectiveness of CPT and CPM in knee function after retrograde femoral nailing. This study was done to compare these methods.
The objective of this study was to evaluate the effectiveness of CPM compared to conventional physical therapy (CPT) in knee function after retrograde femoral nailing.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Injury, Occupational Diseases, Poisoning,Orthopaedics,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
01/07/2014 |
Actual trial start date |
04/07/2016 |
Anticipated date of last follow up |
30/06/2018 |
Actual Last follow-up date |
24/12/2021 |
Anticipated target sample size (number of participants) |
98 |
Actual target sample size (number of participants) |
88 |
Recruitment status |
Completed |
Publication URL |
|
|